VP, Head of Cell & Genetic Medicines Discovery

MeiraGTx Reports Second Quarter 2025 Financial and Operational Results

Interleukin-23 Inhibitors Market to Surge During the Forecast Period (2025-2034) Due to Demand for Targeted Autoimmune Therapies | DelveInsight

Urothelial Carcinoma Market Set to Expand During the Forecast Period (2025-2034) Amid Rising Incidence and Evolving Therapeutic Landscape | DelveInsight

Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi

Global Head, Life Cycle Management ATSC MSAT

Johnson & Johnson Innovative Medicine is a leader in healthcare innovation, dedicated to transforming lives through advanced therapies. The Global Head of Life Cycle Management for the MSAT organization will provide technical and strategic leadership to enhance product lifecycle management and ensure the successful implementation of technology initiatives across manufacturing sites.

Head, Local Medical Safety Operations; Regional Head, Americas

Associate Director, Global Safety Strategy and Risk Management

Global Leader - External Quality CAR-T Director, Advanced Therapies 

Senior Manager, Biotherapeutics R&D

Associate Director Lab Automation and Operations

Sign up with Google

Sign in with Google